Studies
Turn oncology protocols into stakeholder-ready documents in minutes.
6Total Studies
3Processing
2Completed
1Draft
| Study Title | Indication | Phase | Status | Last Updated | Actions |
|---|---|---|---|---|---|
| TRI-NSCLC-201A Phase II Study of TRI-101 in Advanced NSCLC | NSCLC | Phase II | Completed | Oct 27, 2026 | |
| TRI-BRCA-101Combination Therapy in HR+ Breast Cancer | Breast Cancer | Phase I/II | Processing | Oct 27, 2026 | |
| TRI-PANC-101TRI-201 in Metastatic Pancreatic Cancer | Pancreatic Cancer | Phase I | Draft | Oct 26, 2026 | |
| TRI-LUNG-001Biomarker-Driven Study in NSCLC | NSCLC | Phase III | Processing | Oct 25, 2026 | |
| TRI-OVCA-106Maintenance Treatment in Recurrent Ovarian Cancer | Ovarian Cancer | Phase II | Completed | Oct 24, 2026 | |
| TRI-MM-204Relapsed/Refractory Multiple Myeloma Study | Multiple Myeloma | Phase I/II | Processing | Oct 23, 2026 |
Showing 6 of 6 studies